Nutraceuticals Market to 2017 - Food Additives such as Omega-3 Fatty Acids, Probiotics, Soy and Energy Drinks to Perform Strongly

Additional Information

Leading business intelligence provider, GBI Research, has released its latest report, “Nutraceuticals Market to 2017 - Food Additives such as Omega-3 Fatty Acids, Probiotics, Soy and Energy Drinks to Perform Strongly”, which provides key data, information and analysis of the global nutraceutical market.

The report offers a comprehensive insight into the global nutraceutical industry, providing key data and analysis on factors shaping the market and its competitive environment. The report provides details on the market size and forecasts for the seven major markets of the US, Japan, the UK, Spain, Italy Germany and France, and across major segments of the nutraceutical industry. It also provides key information on factors driving and limiting the market and the major companies operating within it. In addition, the report covers the major deals to take place in the global nutraceutical industry during the last five years.

The report is based on proprietary databases, primary and secondary research and in-house analysis conducted by GBI Research’s team of industry experts to provide a comprehensive view of the global nutraceuticals market.

Research conducted by GBI Research indicates that the global nutraceuticals market is forecast to grow at a healthy rate during 2010-2017. An increase in the elderly population, the affluence of the working population and increasing awareness of, and preference for, preventive medicine are expected to be the major factors to stimulate market growth in the top seven countries of the US, Japan the UK, Spain, Italy Germany and France.

Global Nutraceuticals Market Forecast to Witness Moderate Growth

In 2010, the global nutraceuticals market was estimated to be worth $128.6 billion, after increasing at a compound annual growth rate (CAGR) of 4.4% during 2002-2010. Furthermore, the market is forecast to reach $180.1 billion by 2017, after growing at a CAGR of 4.9% throughout 2010-2017. The primary reason for the growth rate is an increase in the elderly population, the affluence of the working population, and awareness of, and preference for, preventive medicine.

Nutraceuticals Market, Global, Sales Value ($bn), 2002-2017

Source: GBI Research, GBI Research’s Internal Database, Company Annual Reports

Increasing Opportunities in Functional Food Segment

The functional food segment dominated the nutraceutical market during the review period. GBI Research’s analysis indicates that the functional food segment accounted for 59.4% of overall global nutraceutical market revenue in 2002. Furthermore, the segment is expected to contribute 64.6% to overall global nutraceutical market revenue in 2017. With a CAGR of 5.3%, the functional food market will witness more growth than the dietary supplement market, which is expected to record a CAGR of 4.3% during 2010-2017. GBI Research also found that the Japanese functional food market will account for 85% of the country’s total nutraceutical market in 2017. The reason for such growth can largely be attributed to an increase in the elderly population, lifestyle changes, the growing incidence of chronic diseases and consequent increasing focus on preventive care in developed economies. The functional food market presents an attractive opportunity to companies operating in the nutraceutical market as the segment is expected to continue to experience expansion and development during the forecast period.

Growth Potential in Nutraceuticals Market Boosts Mergers and Acquisitions

Merger and acquisition (M&A) agreements in the global nutraceuticals market during 2006-2011 remained high, with twenty major acquisition deals. Large pharmaceutical and nutrition companies such as Nestle, Pfizer and Sanofi participated in approximately 30% of acquisition deals, while other major companies such as DSM, NBTY, PepsiCo and BASF accounted for 20% of total acquisition activity. Other companies such as Otsuka, GSK, Plethico, and PanGenex participated in 50% of acquisition deals during the same time period. With the majority of deals involving approved drugs, it suggests that key market participants are demonstrating strong interest in the expansion of their product portfolios, and the improvement of industry presence in global markets.

Nutraceuticals Market, Global, Major Acquisitions by Company (%), 2006-2011

Source: GBI Research, Company Websites, Annual Reports